CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer

BACKGROUND: Induction chemotherapy incorporating docetaxel, cisplatin and 5- fluorouracil before radiotherapy may improve the outcome of patients with advanced head and neck cancer. Nevertheless, the addition of docetaxel increases hematological toxicity and infectious complications. Therefore, gene...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Melchardt, Thomas, Hufnagl, Clemens, Magnes, Teresa, Weiss, Lukas, Hutarew, Georg, Neureiter, Daniel, Schlattau, Alexander, Moser, Gerhard, Gaggl, Alexander, Tränkenschuh, Wolfgang, Greil, Richard, Egle, Alexander
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4609094/
https://ncbi.nlm.nih.gov/pubmed/26475344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1776-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky